Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 9, 2008, Pages 3068-3073

  Margeridon, Séverine ^a,b,e   Carrouée Durantel, Sandra ^c   Chemin, Isabelle ^a,b   Barraud, Luc ^c   Zoulim, Fabien ^a,b,d   Trépo, Christian ^a,b,d   Kay, Alan ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c BioAlliance Pharma   (France)

^d HÔTEL DIEU   (France)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR DIPIVOXIL; CIRCULAR DNA; LAMIVUDINE;

ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER BIOPSY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENOME; VIRUS LOAD;

ANTIVIRAL AGENTS; CARRIER STATE; CELL LINE, TUMOR; DNA, CIRCULAR; DNA, VIRAL; DRUG RESISTANCE, VIRAL; GENOME, VIRAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MOLECULAR SEQUENCE DATA; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SEQUENCE ANALYSIS, DNA; TRANSFECTION; VIRUS REPLICATION;

EID: 50949116278     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01318-07     Document Type: Article

References (26)

1. Alter, M. J. 2006. Epidemiology of viral hepatitis and HIV co-infection. J. Hepatol 44:S6-S9.
2. Blanco, L., A. Bernad, J. M. Lazaro, G. Martin, C. Garmendia, and M-Salas. 1989. Highly efficient DNA synthesis by the phage phi 29 DNA polymerase. Symmetrical mode of DNA replication. J. Biol. Chem. 264: 8935-8940.
3. Blanpain, C., C. Knoop, M. L. Delforge, M. Antoine, M. O. Peny, C. Liesnard, P. Vereerstraeten, E. Cogan, M. Adler, and D. Abramowicz. 1998. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. Transplantation 66:883-886.
4. Chaudhuri, V., R. Tayal, B. Nayak, S. K. Acharya, and S. K. Panda. 2004. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 127:1356-1371.
5. Esteban, J. A., M. Salas, and L. Blanco. 1993. Fidelity of phi 29 DNA polymerase. Comparison between protein-primed initiation and DNA polymerization. J. Biol. Chem. 268:2719-2726.
6. Ganem, D., and R. Schneider. 2001. Hepadnaviridae: the viruses and their replication, p. 2923-2969. In D. Knipe, P. Howley, D. Griffin, R. Lamb, M. Martin, B. Roizman, and S. Strauss (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
7. Günther, S., B. C. Li, S. Miska, D. H. Kruger, H. Meisel, and H. Will. 1995. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J. Virol. 69:5437-5444.
8. Günther, S., G. Sommer, F. Von Breunig, A. Iwanska, T. Kalinina, M. Sterneck, and H. Will. 1998. Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J. Clin. Microbiol. 36:531-538.
9. Hass, M., C. Hannoun, T. Kalinina, G. Sommer, C. Manegold, and S. Günther. 2005. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology 42:93-103.
10. Iwai, K., M. Tashima, M. Itoh, T. Okazaki, K. Yamamoto, H. Ohno, H. Marusawa, Y. Ueda, T. Nakamura, T. Chiba, and T. Uchiyama. 2000. Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period. Bone Marrow Transplant. 25:105-108.
11. Jeantet, D., I. Chemin, B. Mandrand, F. Zoulim, C. Trépo, and A. Kay. 2002. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology 35:1215-1224.
12. Kramvis, A., and M. C. Kew. 1999. The core promoter of hepatitis B virus. J. Viral Hepat. 6:415-427.
13. Lasken, R. S., and M. Egholm. 2003. Whole genome amplification: abundant supplies of DNA from precious samples or clinical specimens. Trends Biotechnol. 21:531-535.
14. Lien, J. M., C. E. Aldrich, and W. S. Mason. 1986. Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J. Virol. 57:229-236.
15. Lucifora, J., D. Durantel, L. Belloni, L. Barraud, S. Villet, I. E. Vincent, S. Margeridon-Thermet, O. Hantz, A. Kay, M. Levrero, and F. Zoulim. 2008. Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector. J. Gen. Virol. 89:1819-1828.
16. Margeridon, S., A. Lachaux, C. Trépo, F. Zoulim, and A. Kay. 2005. A quasi-monoclonal anti-HBs response can lead to immune escape of "wildtype" hepatitis B virus. J. Gen. Virol. 86:1687-1693.
17. Maynard, M., P. Parvaz, S. Durantel, M. Chevallier, P. Chevallier, M. Lot, C. Trépo, and F. Zoulim. 2005. Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure. J. Hepatol. 42:279-281.
18. Michalak, T. I. 2000. Occult persistence and lymphotropism of hepadnaviral infection: insights from the woodchuck viral hepatitis model. Immunol. Rev. 174:98-111.
19. Moraleda, G., J. Saputelli, C. E. Aldrich, D. Averett, L. Condreay, and W. S. Mason. 1997. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J. Virol. 71:9392-9399.
20. Norder, H., A. M. Courouce, P. Coursaget, J. M. Echevarria, S. D. Lee, I. K. Mushahwar, B. H. Robertson, S. Locarnini, and L. O. Magnius. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309.
21. Pollicino, T., G. Squadrito, G. Cerenzia, I. Cacciola, G. Raffa, A. Craxi, F. Farinati, G. Missale, A. Smedile, C. Tiribelli, E. Villa, and G. Raimondo. 2004. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126:102-110.
22. Tong, S. P., J. S. Li, L. Vitvitski, A. Kay, and C. Trépo. 1993. Evidence for a base-paired region of hepatitis B virus pregenome encapsidation signal which influences the patterns of precore mutations abolishing HBe protein expression. J. Virol. 67:5651-5655.
23. Werle-Lapostolle, B., S. Bowden, S. Locarnini, K. Wursthorn, J. Petersen, G. Lau, C. Trépo, P. Marcellin, Z. Goodman, W. E. T. Delaney, S. Xiong, C. L. Brosgart, S. S. Chen, C. S. Gibbs, and F. Zoulim. 2004. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126:1750- 1758.
24. Werle, B., K. Cinquin, P. Marcellin, S. Pol, M. Maynard, C. Trépo, and F. Zoulim. 2004. Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy. J. Viral Hepat. 11:74-83.
25. Wu, T. T., L. D. Condreay, L. Coates, C. Aldrich, and W. Mason. 1991. Evidence that less-than-full-length pol gene products are functional in hepadnavirus DNA synthesis. J. Virol. 65:2155-2163.
26. Zhang, D. Y., M. Brandwein, T. Hsuih, and H. B. Li. 2001. Ramification amplification: a novel isothermal DNA amplification method. Mol. Diagn. 6:141-150.